Oklahoma Silicone Breast Implant
Breast augmentation has become one of the most popular plastic surgery procedures to have performed. In 2004, 264,041 breast augmentation procedures were performed. As the popularity of breast augmentation has grown, so has the concern over the safety of the breast implants being used.
The first silicone breast implants were developed in Texas by two plastic surgeons and were implanted in their first patient in 1962. While today the use of saline implants is far wider than silicone that was not always the case. Since 1977, many lawsuits have been filed alleging that Dow Corning and other silicone breast implant manufacturers knew of potential dangers of silicone breast implants.
Contact us today if you or a loved one has been injured or killed as a result of silicone breast implants by using the form on your left or by calling us toll-free at 1 (866) 664-0400 for a FREE case review.
The potential dangers of silicone breast implants may include:
- Auto-Immune Disease (such as Lupus)
- Eye and Mental Problems
- Facial Tics
In January 1992 the FDA halted the distribution and implantation of silicone breast implants, and then in April of that same year their use was limited to only those women undergoing breast reconstruction. Today in the United States saline implants are the most widely used implant, but in Europe they continue to be the most popular choice.
American University researchers announced that they found elevated levels of platinum in women with silicone breast implants. The type of platinum found was not the normal type of platinum found in the human body, and the levels found could result in mental, visual or facial problems.
If you or a loved is suffering side effects believed to be associated with either silicone or saline implants, a doctor should be consulted immediately.
Silicone Breast Implant Diseases
Listed below are a few of the possible complications and diseases associated with Silicone Breast Implants along with brief descriptions of the symptoms.
Occurs when a specific adaptive immune response is mounted against the self. It is not known what triggers the autoimmune response, but susceptibility to most autoimmune diseases shows a significant genetic component. Environmental factors such as infection or diet are likely to play a role in pathogenesis.
Non-specific affection of the joints, slow in progress, producing a painful thickening and contraction of the fibrous structures, interfering with motion and causing deformity.
Structures that bind and support the body, such as tendons, joints, ligaments, bones, cartilage, and synovium or joint lining. The blood and lymph may be regarded as connective tissue as well.
Connective tissue disease(s)
Any of a group of diseases, as systemic lupus erythmetosus, polyarteritis, scleroderma, and rheumatoid arthritis, involving inflammation or degeneration of connective tissue and accompanied by deposition of fibrous material.
Fibromyalgia is used to denote aching, soreness or stiffness; commonly associated problems are fatigue, sleep disturbance, headaches.
A classical term for any disorder affecting any segment of the nervous system. In contemporary usage, a disease involving the cranial or spinal nerves.
An indefinite term applied to various conditions with pain or other symptoms which are joint-related to other elements of the musculoskeletal system.
A common inflammatory joint disease that is probably due to an autoimmune response. The disease is accompanied by the production of rheumatoid factor, an IgM anti-IgG antibody that may also be produced in normal immune responses.
Scleroderma or Dermatosclerosis
Hide-bound or skinbound disease; thickening of the skin caused by swelling and thickening of fibrous tissue, with eventual atrophy of the epidermis (skin layer); a manifestation of progressive systemic sclerosis.
Systemic Lupus Erythematosus (SLE)
An inflammatory connective tissue disease with variable features, frequently including fever, weakness and fatigability, joint pains or arthritis resembling rheumatoid arthritis, diffuse erythematous skin lesions on the face, neck, or upper extremities, with liquefaction degeneration of the basal layer and epidermal atrophy, lymphadenopathy (enlarged lymph nodes), pleurisy (inflammation of membrane around lungs) or pericarditis (inflammation of membrane around the heart), glomerular lesions (of the capillaries) , anemia, hyperglobulenemia, a positive L.E. cell test, and other evidence of autoimmune phenomenon.
We can handle your potential legal case if you are in any of these Oklahoma cities. Even if your city is not listed you may still speak with one of our Oklahoma product liability attorneys by filling out our contact form or calling us toll-free at 1 (866) 664-0400.
Ada, Afton, Altus, Alva, Anadarko, Ardmore, Atoka, Bartlesville, Blackwell, Broken Arrow, Catoosa, Chandler, Checotah, Chickasha, Claremore, Clinton, Del City, Duncan, Durant, Edmond, El Reno, Elk City, Enid, Erick, Frederick, Glenpool, Grove, Guthrie, Guymon, Henryetta, Idabel, Lawton, Locust Grove, Mcalester, Miami, Midwest City, Moore, Muskogee, Norman, Oklahoma City, Okmulgee, Owasso, Pauls Valley, Perry, Ponca City, Poteau, Pryor, Roland, Sallisaw, Sand Springs, Savanna, Shawnee, Stillwater, Stilwell, Stroud, Tahlequah, Tulsa, Vinita, Wagoner, Weatherford, Woodward, Yukon
Copyright © 2006 Garrett Law Office, P.C.
111 W 5th Street | Tulsa, OK 74145
Phone: 918-622-9292 | Fax: 918-549-6794